# QPID

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/qpid

- Industry: Healthcare IT
- Headquarters: Boston, US
- Total disclosed funding: $17M
- Latest round: Series B (May 2, 2014)
- Investors on record: 4

## About

QPID, Inc. is a health technology company specializing in clinical decision support and data analytics to improve patient care and streamline healthcare operations.Founded in 2012 in Boston, US, QPID, Inc. focuses on enhancing clinical workflow through innovative health technology solutions. The company has undergone strategic pivots to refine its offerings and expand its market reach. In February 2016, QPID was acquired by eviCore Healthcare, though financial terms of the deal were not disclosed. The company has raised a total of USD 12.30 mn across Series B funding, led by New Leaf Venture Partners, with participation from Cardinal Partners, Mass General Brigham Ventures, and Matrix Partners. The latest funding round occurred on February 26, 2016.QPID, Inc. provides advanced clinical decision support tools and analytics services aimed at optimizing healthcare delivery. Its products assist healthcare professionals in making informed decisions by leveraging data to enhance patient outcomes. The company's solutions cater to a diverse clientele in the healthcare sector, aiming to improve operational efficiency and clinical care quality.QPID, Inc. generates revenue through its specialized health technology services, relying on strategic partnerships and collaborations within the healthcare industry. Its business model emphasizes collaborative development and implementation of technology solutions, enhancing healthcare operations rather than traditional sales-driven approaches.In light of its recent acquisition by eviCore Healthcare, QPID, Inc. is expected to focus on integrating its technology within eviCore's healthcare frameworks. This will likely involve the development and launch of new products designed to enhance patient management and analytics capabilities. The company plans to expand its market presence further into various regions, though specific geographical targets have yet to be disclosed. The funding from Series B will support these initiatives, particularly in enhancing product development and operational capacity.

## Funding rounds

- Series B, May 2, 2014, $12M — Cardinal Partners, Matrix Partners, New Leaf Venture Partners, Mass General Brigham Ventures
- Series A, Mar 20, 2013, $4.4M — Cardinal Partners, Matrix Partners, Mass General Brigham Ventures

## Investors

- Cardinal Partners (https://capitalatlas.ai/funds/cardinal-partners) — Series A, Series B
- Matrix Partners (https://capitalatlas.ai/funds/matrix-partners) — Series A, Series B
- Mass General Brigham Ventures (https://capitalatlas.ai/funds/mass-general-brigham-ventures) — Series A, Series B
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series B